Skip to main content
editor.ajphr@gmail.com
9409046853
e-ISSN: 2321-3647
American Journal of Pharmacy and Health Research

American Journal of Pharmacy and Health Research

Published

Azoxymethane in Experimental Pharmacology: Molecular Mechanisms, Colorectal Carcinogenesis and Therapeutic Research Applications

Published in November 2026 Issue 11 (Vol. 14, Issue 11, 2026)

Azoxymethane in Experimental Pharmacology: Molecular Mechanisms, Colorectal Carcinogenesis and Therapeutic Research Applications - Issue cover

Abstract

Azoxymethane (AOM) is a synthetic alkylating procarcinogen widely employed in experimental pharmacology, toxicology and molecular oncology for investigating colorectal carcinogenesis. Although it does not possess an established therapeutic indication, its pharmacological and toxicological properties provide an important experimental framework for understanding chemical carcinogenesis and evaluating potential chemopreventive and anticancer interventions. Following metabolic activation, principally through cytochrome P450-dependent pathways, AOM generates methylating intermediates capable of producing DNA adducts, including O⁶-methylguanine. These alterations contribute to mutagenesis, epithelial dysregulation and colorectal tumour initiation. The combination of AOM with dextran sodium sulphate (DSS) has further established a reproducible experimental model of inflammation-associated colorectal cancer. This review examines the historical development, chemical characteristics, pharmacokinetic considerations, metabolic bioactivation, molecular mechanisms, cellular responses and toxicological profile of AOM. Particular attention is given to DNA damage, DNA repair mechanisms, KRAS and Wnt/β-catenin signalling, NF-κB activation, oxidative stress, NLRP3 inflammasome activity, apoptosis, autophagy and interactions with the intestinal microbiome. Contemporary applications in pharmacological research, including chemoprevention, natural-product evaluation, immunotherapy, microbiome-directed interventions and experimental drug screening, are discussed. Recent developments through 2026 highlight the importance of standardising AOM/DSS models and integrating microbiome, metabolomic and lipidomic investigations. The review concludes that AOM remains an important experimental carcinogenesis tool, provided its carcinogenic nature, model limitations and lack of direct therapeutic utility are recognised. Its principal translational value lies in facilitating the discovery and preclinical evaluation of safer and more effective colorectal cancer prevention and treatment strategies.

Authors (1)

Devansh Mehta

Independent Researcher and Sci...

View all publications →

Download Article

PDF

Best for printing and citation

File size: 0.6 MB
Format: PDF

Summarise this paper with AI:

Article Information

AJPHR11140000

AJPHR-01-000979

74-97

2026-11-16

JATS XML

Article Impact

Views:2,924
Downloads:1,789

How to Cite

Mehta, D. (2026). Azoxymethane in Experimental Pharmacology: Molecular Mechanisms, Colorectal Carcinogenesis and Therapeutic Research Applications. American Journal of Pharmacy and Health Research, 14(11), 74-97. https://ajphr.com/articles/AJPHR11140000

Article Actions

Whatsapp